Skip to content
LegitScript certified  ·  Licensed US clinicians in all 50 states  ·  Free shipping  ·  Cancel anytime
Womea
Blog

Fezolinetant vs paroxetine vs gabapentin for hot flashes

If hormone therapy is not right for you, four prescription medications have real evidence for hot flashes: fezolinetant, low-dose paroxetine, venlafaxine, and gabapentin. Here is how they compare, drug by drug.

August 22, 20267 min readMedically reviewed by Sean Arora, MD

Four prescription medications have meaningful evidence for treating hot flashes without hormones: fezolinetant, a purpose-built NK3-receptor antagonist; low-dose paroxetine, the only SSRI the FDA has approved specifically for hot flashes; venlafaxine; and gabapentin. They differ in how they work, what they cost, and what they ask of you in side effects. Womea does not prescribe these medications; this comparison exists because choosing between them is a real decision many women face, and the evidence deserves to be laid out plainly.

How do the four medications compare?

Prescription non-hormonal options for hot flashes, at a glance
MedicationHow it worksFDA status for hot flashesMost relevant trade-off
Fezolinetant (Veozah)Blocks NK3 receptors in the brain's temperature-regulation circuitApproved (2023) for moderate to severe vasomotor symptomsNewest and typically most expensive; requires periodic liver-enzyme monitoring
Paroxetine 7.5 mg (Brisdelle)Low-dose SSRI; the mechanism for hot flashes is serotonergicApproved (2013) specifically for vasomotor symptomsCan interact with tamoxifen; a consideration after breast cancer
VenlafaxineSNRI shown to reduce hot flash frequency and severityNot approved for hot flashes; guideline-recommended useOften chosen when mood symptoms coexist; dose-dependent side effects
GabapentinCalms neuronal excitability; reduces flashes, especially at nightNot approved for hot flashes; guideline-recommended useDrowsiness, which becomes useful when dosed in the evening for night sweats
Fezolinetant, low-dose paroxetine, other selected SSRIs and SNRIs, and gabapentin are recommended nonhormone options with evidence for treating vasomotor symptoms.
The Menopause Society, 2023 Nonhormone Therapy Position Statement

When does each one tend to make sense?

  • Fezolinetant: you want a medication designed for hot flashes specifically, without hormonal or antidepressant effects, and cost or insurance coverage works out. Liver enzymes are checked before and during treatment.
  • Low-dose paroxetine: you want the option with a specific FDA approval at a dose well below antidepressant strength. Not combined with tamoxifen, which it can make less effective.
  • Venlafaxine: hot flashes arrive alongside mood symptoms, and treating both with one medication appeals. It is also a common choice after breast cancer because it does not interfere with tamoxifen.
  • Gabapentin: night sweats and broken sleep are the core complaint. Taken in the evening, the drowsiness that is a side effect by day works in your favor at night.

How well do they work compared with estrogen?

Honestly: less well, for most women. Estradiol remains the most effective treatment for hot flashes and night sweats, which is why hormone therapy stays the first conversation for healthy women within about ten years of menopause. The non-hormonal options typically reduce hot flash frequency meaningfully but less than estrogen does, and each carries its own side-effect profile. Their real role is for women who cannot take estrogen, such as after certain cancers or clotting events, or who simply prefer not to. Our overview of non-hormonal options for menopause covers the full landscape, including the non-prescription approaches.

Womea prescribes body-identical hormone therapy after a live clinician visit; we do not prescribe fezolinetant, paroxetine, venlafaxine, or gabapentin. If a non-hormonal prescription is the right path for you, this comparison is meant to make that conversation with your own clinician faster and better informed.

The bottom line

There is no single best non-hormonal option, only a best fit for a specific situation: purpose-built and hormone-free (fezolinetant), a minimal-dose SSRI the FDA has cleared for this use (paroxetine 7.5 mg), mood and flashes together or post-tamoxifen (venlafaxine), or nights first (gabapentin). Whichever direction you lean, the decision runs through a clinician who knows your history, and how to prepare for that conversation is the same whether the prescription ends up hormonal or not.

FAQ

Questions, answered

Neither is better across the board. Gabapentin is often chosen when night sweats and disrupted sleep dominate, because evening dosing turns its drowsiness into an asset. Low-dose paroxetine is the only SSRI with FDA approval for hot flashes and suits daytime symptoms, but it is avoided with tamoxifen. A clinician matches the choice to your pattern and history.

Feel like yourself again.

Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.

Free shipping · Cancel anytime · HSA / FSA eligible · No membership fee